Page last updated: 2024-12-06

1,3,5-triamino-2,4,6-trinitrobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3,5-triamino-2,4,6-trinitrobenzene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID18286
SCHEMBL ID438677
MeSH IDM0500969

Synonyms (28)

Synonym
1,3,5-benzenetriamine, 2,4,6-trinitro-
sym-triaminotrinitrobenzene
nsc243156
1,5-triamino-2,4,6-trinitrobenzene
1,5-benzenetriamine, 2,4,6-trinitro-
2,6-trinitro-1,3,5-benzenetriamine
nsc-243156
tatb
3058-38-6
s-triaminotrinitrobenzene
1,3,5-triamino-2,4,6-trinitrobenzene
nsc 243156
2,4,6-trinitro-1,3,5-benzenetriamine
brn 2225411
2,4,6-trinitrobenzene-1,3,5-triamine
einecs 221-297-5
tatb cpd
cjp3unx7z7 ,
3-13-00-00556 (beilstein handbook reference)
unii-cjp3unx7z7
FT-0675393
SCHEMBL438677
DTXSID8062818
trinitro-1,3,5-benzenetriamine, 2,4,6-
2,4,6-triamino-1,3,5-trinitrobenzene
AKOS030239774
J-018029
Q420723
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (33.33)29.6817
2010's10 (66.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.00 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]